Medicure Inc.
Presenter: Dawson Reimer, VP, Operations
Company Information
Company Type: Pharmaceuticals
Development Stage: Public
Company Profile
Medicure Inc is a biopharmaceutical company focused on the research, development and commercialization of novel small molecules to treat cardiovascular and neurological disorders. The Companys primary business activity is the marketing and distribution of AGGRASTAT® (tirofiban hydrochloride) in the United States for acute coronary syndromes.
Company Strategy
Increase sales of our cardiovascular drug through addition of new indications and development of new product formats.
Programs
US Commercial subsidiary(Medicure Pharma, Inc., New Jersey)
Phase II Study Underway for treatment of Tardive Dyskinesia, a movement disorder caused by use of various CNS acting drugs.
Phase III Study preparations underway for use of Aggrastat in Percutaneous Coronary Intervention (PCI)
Investors
Public company
Management Team
Albert Friesen, PhD President & CEO
Dawson Reimer, MAES, Vice President, Operations
Presenter Bio
Dawson J. Reimer, MAES, Vice President, Operations
Dawson Reimer proceeded from a Master's in Economic Development, University of Waterloo to be employed with the Federal Department of Western Diversification in the area of business start-up training. Following this, he served as Business Development/Investor Relations with Genesys Pharma Inc., a biotechnology research company, and then in 1997, began conducting business activities for Genesys Venture Inc., a biotech business incubator, where he worked with several start-up biotechnology ventures. In this capacity, Mr. Reimer became actively involved in Medicure at its inception and has been directly employed by Medicure since 2001. His current volunteer activities include serving as President and Chair of the Life Science Association of Manitoba and on the Board of Destination Winnipeg, the city's economic development and tourism agency.
Mr. Reimer also serves as Secretary, Medicure Pharma, Inc. Somerset, NJ.
Contact
Medicure Inc.
2-1250 Waverley Street
Winnipeg
Manitoba, Canada
R3T 6C6
ph: 204-487-7412
fx: 204-488-9823
www.medicure.com
dreimer@medicure.com